Skip to main content
. 2012 Aug 16;7(8):e43437. doi: 10.1371/journal.pone.0043437

Figure 2. JAK2 mutations display resistance to JAK Inhibitor-I.

Figure 2

BaF3 hematopoietic cells expressing the construct indicated were treated for 48 hours in cytokine-free medium containing two-fold increasing concentrations of JAK Inhibitor-I. Cell viability was determined using the XTT assay. The figure is representative of three independent experiments.